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Abstract
Fast-scan cyclic voltammetry (FSCV) at carbon-fiber microelectrodes has been used to
demonstrate that sub-second changes in catecholamine concentration occur within the nucleus
accumbens (NAc) shell during motivated behaviors, and these fluctuations have been attributed to
rapid dopamine signaling. However, FSCV cannot distinguish between dopamine and
norepinephrine, and caudal regions of the NAc shell receive noradrenergic projections. Therefore,
in the present study, we examined the degree to which norepinephrine contributes to
catecholamine release within rostral and caudal portion of NAc shell. Analysis of tissue content
revealed that dopamine was the major catecholamine detectable in the rostral NAc shell, whereas
both dopamine and norepinephrine were found in the caudal subregion. To examine releasable
catecholamines, electrical stimulation was used to evoke release in anesthetized rats with either
stimulation of the medial forebrain bundle, a pathway containing both dopaminergic and
noradrenergic projections to the NAc, or the ventral tegmental area/substantia nigra, the origin of
dopaminergic projections. The catecholamines were distinguished by their responses to different
pharmacological agents. The dopamine autoreceptor blocker, raclopride, as well as the monoamine
and dopamine transporter blockers, cocaine and GBR 12909, increased evoked catecholamine
overflow in both the rostral and caudal NAc shell. The norepinephrine autoreceptor blocker,
yohimbine, and the norepinephrine transporter blocker, desipramine, increased catecholamine
overflow in the caudal NAc shell without significant alteration of evoked responses in the rostral
NAc shell. Thus, the neurochemical and pharmacological results show that norepinephrine
signaling is restricted to caudal portions of the NAc shell. Following raclopride and cocaine or
raclopride and GBR 12909, robust catecholamine transients were observed within the rostral shell
but these were far less apparent in the caudal NAc shell, and they did not occur following
yohimbine and desipramine. Taken together, the data demonstrate that catecholamine signals in
the rostral NAc shell detected by FSCV are due to change in dopamine transmission.
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Dopamine transmission within the nucleus accumbens (NAc) shell, a small region of the
basal forebrain, is involved in information processing that mediates reward. Because of the
role of dopamine in addiction and motivated behavior (Wise 2002; Di Chiara 1995; Aragona
et al. 2008; Owesson-White et al. 2008), there have been extensive studies of dopamine
transmission within this region. In our laboratories, we have used fast-scan cyclic
voltammetry (FSCV) with a carbon-fiber microelectrode to correlate real-time dopamine
transmission in the rostral NAc shell during associative learning and intake of drugs of
abuse (Owesson-White et al. 2008; Phillips et al. 2003; Aragona et al. 2009). Dopamine was
identified by the similarity of the cyclic voltammogram recorded in vivo with in vitro
calibrations for dopamine. The cyclic voltammogram for dopamine is distinct from all
neurochemicals that have been tested except norepinephrine (Baur et al. 1988; Heien et al.
2003). However, the cyclic voltammograms for dopamine and norepinephrine are virtually
identical (Heien et al. 2004; Park et al. 2009), and thus independent confirmation of the
specific catecholamine detected is required.
The dense dopaminergic innervation of the NAc shell is primarily from the cell bodies that
originated in the ventral tegmental area (VTA). Anatomical studies have revealed that the
NAc shell also receives a noradrenergic input to caudal portions of this structure (Berridge
et al. 1997; Schroeter et al. 2000; Delfs et al. 1998). These noradrenergic inputs originate
primarily from the A2 cell group in the nucleus tractus solitarius (NTS) (Delfs et al. 1998)
and A6 cell group in the locus coeruleus (Berridge et al. 1997). The neurons from the NTS
project through the ventral noradrenergic bundle (VNB) and the medial forebrain bundle
(MFB) to the NAc shell. The neurons from the locus coeruleus project through the dorsal
noradrenergic bundle (DNB) and the MFB to the NAc shell. Importantly, both noradrenergic
projections to the NAc primarily terminated within the caudal NAc shell.
Immunohisotchemical studies suggest that the rostral NAc shell receives little noradrenergic
innervation (Berridge et al. 1997; Schroeter et al. 2000; Delfs et al. 1998), however,
interpretation of cyclic voltammetric data with respect to the specific catecholamine detected
requires that the dopamine/norepinephrine distribution is understood in more detail.
In the current study, we characterized catecholamine (dopamine and norepinephrine) content
and overflow in both the medial rostral and caudal regions of the NAc shell. Because there is
no delineating feature that defines the division of the medial rostral shell from the medial
caudal shell, a variety of stereotaxic coordinates have been used by various groups
(Heidbreder & Feldon 1998; Hajnal & Norgren 2004). We defined the medial rostral shell as
the region of the NAc that extends from 1.45 to 1.90 mm anterior of bregma. The medial
caudal NAc shell is defined here as the region from 0.70 to 1.20 mm anterior of bregma.
Catecholamine release in anesthetized rats was evoked by electrical stimulation of the MFB,
a fiber bundle that contains the majority of both the noradrenergic and dopaminergic fibers
that project to the NAc shell. The other region stimulated was the VTA/substantia nigra
(VTA/SN), a region that contains dopaminergic neurons and through which passes a portion
of the VNB (Park et al. 2009; Ungerstedt 1971). The combined anatomical, neurochemical,
and pharmacological characterization show that the major catecholamine released in the
rostral NAC shell is dopamine whereas a mixture of dopamine and norepinephrine is
released in the caudal NAc shell.
Park et al. Page 2















Adult male Sprague-Dawley rats (320–400g) were purchased from Charles Rivers
(Wilmington, MA) and housed in temperature and humidity controlled rooms with ad
libitum food and water with a 12/12 hr light/dark cycle. All procedures for handling and
caring for the laboratory animals were in accordance with the NIH Guide for Care and Use
of Laboratory Animals and were approved by the Institutional Animal Care and Use
Committee of the University of North Carolina at Chapel Hill.
Surgery
Rats were anesthetized with urethane (1.5 mg/kg) and immobilized in a stereotaxic frame
(David Kopf Instruments, Tujunga, CA). Temperature was maintained at 37 °C with a
heating pad (Harvard Apparatus, Holliston, MA). Small holes on the skull were drilled for
reference (Ag/AgCl) and stimulating electrodes as well as the carbon-fiber microelectrodes.
The dura mater was punctured, carefully removed, and a single carbon-fiber microelectrode
was lowered into the rostral (AP +1.7 mm, ML + 0.8 mm, DV 6.0 – 8.0 mm from bregma)
or caudal (AP + 1.0 mm, ML + 0.9 mm, DV 6.0 – 8.0 mm from bregma) NAc shell,
coordinates taken from the atlas of (Paxinos & Watson 2007). An Ag/AgCl reference
electrode was placed in the contralateral cortex, and it was secured with dental cement.
Electrical stimulation was accomplished with a bipolar, stainless-steel electrode (0.2 mm in
diameter, Plastics One, Roanoke, VA) insulated to the tip. The tips of the bipolar electrode
were separated by ~1.0 mm. It was placed into the MFB (AP −4.0 mm, ML +1.4 mm, DV
8.0–9.0 mm) or the VTA/SN (AP −5.2 mm, ML +1.0 mm, DV 8.0–9.0 mm).
Electrical stimulation
Computer-generated stimulus trains, (NL 800A, Neurolog, Medical Systems Corp., Great
Neck, NY, U.S.A.), were optically isolated from the electrochemical system. The trains
consisted of biphasic pulses (300 μA, 2 ms each phase) with stimulation frequencies
between 10 and 60 Hz applied through the bipolar electrode. Unless noted otherwise, the
number of stimulus pulses was 24. The time interval between electrical stimulations was 4
or 5 min to ensure reproducible catecholamine concentrations were released with each
stimulation (Park et al. 2009).
Voltammetric procedures
Glass-encased, cylindrical carbon-fiber microelectrodes and Ag/AgCl reference electrodes
were prepared as described previously (Cahill et al. 1996). T-650 carbon fibers (5.1 μm in
nominal diameter, Thornel, Amoco Corp., Greenville, SC) with an exposed length of 75 –
100 μm were used. Fast-scan cyclic voltammetry was computer-controlled and has been
described in detail previously (Heien et al. 2003). A triangular scan (−0.4 to +1.3 V, 400V/s)
was repeated every 100 ms. Data was digitized and stored on a computer using software
written in LABVIEW (National Instruments). Background-subtracted cyclic
voltammograms were obtained by digitally subtracting voltammograms collected during
stimulation from those collected during baseline recording. Voltammetric responses were
viewed as color plots with the abscissa as voltage, the ordinate as acquisition time, and the
current encoded in color (Michael et al. 1998). Temporal responses were determined by
monitoring the current at the peak oxidation potential for dopamine in successive
voltammograms or by principal component regression (Heien et al. 2005) as noted in the
text. The current was converted to concentration based on calibration curves obtained after
the in vivo experiment with known concentrations of dopamine in vitro.
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At the end of experiments, electrode placements were verified by stereotaxically lowering a
tungsten electrode to the original position of the carbon-fiber microelectrode or directly with
the carbon-fiber microelectrodes as described earlier (Garris & Wightman 1994b; Park et al.
2009). When the carbon-fiber microelectrode (27 of 57 electrodes used in this study) was
used to lesion the brain, this precluded postcalibration of the electrode sensitivity and
instead, we used a postcalibration factor (9.3 ± 0.5 nA/μM for dopamine), based on the
average response obtained from more than 10 electrodes. The average geometric area of
these electrodes (average length = 81.3 μm, diameter = 5.1 μm) was 1323 μm2. Thus the
sensitivity factor for the T650 carbon-fibers used in this work was 6.9 ± 0.3 pA/(μM·μm2).
A lesion was made at the recording site by applying constant current (20 μA for 10 s) to the
tungsten or carbon-fiber electrodes. Brains were removed from the skull and stored in 10 %
formaldehyde for at least 3 days, and coronally sectioned into 40–50 μm thick slices with a
cryostat. The sections mounted on slides were stained with 0.2 % thionin, and coverslipped
before viewing under a light microscope.
High performance liquid chromatography (HPLC)
HPLC analysis of tissue content of catecholamines followed previously published
procedures (Park et al. 2009). Briefly, the brain of an anesthetized rat was rapidly removed
and placed on ice. Coronal brain slices (500 μm thick) were prepared in ice cold artificial
cerebral spinal fluid (aCSF) using a Lancer Vibratome (World Precision Instruments,
Sarasota, Fl.). The slice containing the rostral NAc shell was adjacent to the slice containing
the caudal NAc shell. The dorsal shell region in these slices was dissected on a dry stainless
steel surface while taking care to avoid inclusion of the adjacent NAc core and ventral
pallidum. The resultant tissue was wet weighed in a pre-tared volume of 200 μL 0.1 N
HClO4 containing 1 μM hydroquinone (HQ) and homogenized with a sonic dismembrator
(Fisher Sci., Model 60, Pittsburgh, PA, USA). The sample was then centrifuged at 6000 g
for 10 min and the supernatant was removed and filtered using a 0.2-μm syringe microfilter
(Millex-LG). Injections (10 μL) were made onto a reverse phase column (C-18, 5 μm, 4.6 ×
250 mm, Waters symmetry 300). The mobile phase (prepared in HPLC grade water)
contained 0.1 M citric acid, 1 mM hexyl sodium sulfate, 0.1 mm EDTA, and 10% methanol
(pH 3.5) at a flow rate of 1 mL/min. Catecholamines were detected with a thin-layer radial
electrochemical cell (BASi, West Lafayette, IN, USA) at 700 mV versus a Ag/AgCl
reference electrode. Catecholamine standards were prepared from 10 mM stock solutions in
0.1 N HClO4. A Labview stripchart recorder program (Jorgenson Lab, UNC-CH) was used
for data collection through home built electronic equipment. The ratio of the peak area of the
analyte to that of the internal standard (HQ) was used to calculate the amount of
catecholamine in the original tissue sample.
Drugs and reagents
All chemicals and drugs were reagent-quality and were used without additional purification.
Drugs were obtained from Sigma-Aldrich (St. Louis, MO, USA). In vitro dopamine
postcalibration of carbon-fiber microelectrodes was done in a Tris buffer solution at pH 7.4
containing 15 mM Tris, 140 mM NaCl, 3.25 mM KCl, 1.2 mM CaCl2, 1.25 mM NaH2PO4,
1.2 mM MgCl2, and 2.0 mM Na2SO4 in double distilled water (Mega Pure System, Corning
Glasswork, Corning, NY). Desipramine-HCl, cocaine-HCl, raclopride-HCl, and yohimbine-
HCl were dissolved in saline. GBR 12909-HCl was dissolved in a small volume of distilled
water and diluted with saline. Injected volumes were 0.6 ml/kg and were given
intraperitoneally (i.p.).
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Clampfit 8.1 as part of pCLAMP 8.1 software package (Axon Instruments, Foster City, CA,
USA) was used to analyze time values such as tmax and t1/2 and signal amplitude values
according to procedures described in the literature (Park et al. 2007). tmax is the time to
reach the maximum concentration and t1/2, was taken as the time to descend from its
maximum value to half of that value. [CA]max is the maximal evoked catecholamine
concentration. Catecholamine transients were identified by principal component regression
algorithm written into the Tar Heel CV software as descried earlier (Heien et al. 2004;
Keithley et al. 2009). Catecholamine transients were defined as anything greater than five
times the root-mean-square noise level and were analyzed for frequency, amplitude, and
duration using Mini Analysis Software (Synaptosoft, Decatur, GA, USA). Data are
represented as mean ± S.E.M. and `n' values indicating the number of rats. Statistical
significance of changes in [CA]max and t1/2 values before and after drugs was determined
using a 2 × 2 × 2 repeated measures ANOVA followed by a t-test post-hoc analysis with a
Bonferroni correction for multiple comparison for brain region (rostral and caudal shell),
drugs (yohimbine and yohimbine + desipramine, raclopride and raclopride + cocaine or
raclopride + cocaine and raclopride + GBR 12909) and stimulation region (MFB and VTA/
SN) as the three variables. Statistical significance of [CA]max, t1/2, and tmax values was
determined using a 2 × 2 repeated ANOVA followed by a t-test post-hoc analysis with a
Bonferroni correction for multiple comparison for brain region (rostral and caudal shell) and
stimulation region (MFB and VTA/SN) as the two variables. Statistical analysis employed
GraphPad Software version 4.0 (San Diego, CA, USA) or SPSS 14.0 software (SPPS,
Chicago, IL). Differences were considered significant when the P value was < 0.05.
Results
Catecholamine content of the rostral and caudal NAc shell
The rostral and caudal NAc shell were dissected from fresh brains and their catecholamine
content determined by HPLC (Table 1). The dopamine tissue content in the rostral and
caudal NAc regions was not significantly different (t = 0.99, d.f. = 25, P = 0.33). Dopamine
was a major catecholamine in the rostral NAc shell. Only a very low amount of
norepinephrine was found (norepinephrine was present in one of fifteen samples from 5
rats), but both dopamine and norepinephrine were present in significant amounts in the
caudal NAc shell. The ratio of norepinephrine to dopamine content for the caudal NAc shell
was ~ 1 to 3. Serotonin was not detected in either subregion.
Electrically stimulated catecholamine release in the rostral NAc shell
Catecholamine release was measured by fast-scan cyclic voltammetry in the rostral NAc
shell during electrical stimulation (60 Hz, 24 pulses, 300 μA) of either the VTA/SN or the
MFB. When the stimulating electrode was above or below these stimulation sites,
catecholamine release in the NAc shell was not observed. Representative examples of the
time courses are shown in Figure 1A. With either location of the stimulating electrode,
catecholamine release began immediately upon stimulus initiation, reached a similar
maximum, and the concentration returned to its initial value after the stimulation. Cyclic
voltammograms recorded at the maximum were identical to those for catecholamines
recorded after in vivo use (Figure 1A, right panel), with the maximum oxidation current
observed at ~ + 0.65 V and the peak for the reduction of the electrochemically formed
quinone at ~ −0.2 V on the reverse scan. Shown in the right panel of Figure 1B is a
photograph of a brain slice used for histological verification of the location of the carbon-
fiber microelectrode. The black arrow points to the location of the electrode tip when the
lesion was made. The lesion sites for all from carbon-fiber electrodes in the rostral NAc
shell are shown in are shown in Supplementary Figure 1, left panel.
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To characterize the distribution of catecholamine release sites in the rostral NAc shell,
release evoked by 60 Hz stimulation was measured at different depths with fast-scan cyclic
voltammetry with stimulating electrodes placed either in the MFB or VTA/SN. Figure 1B
(left panel) shows the coronal plane in which measurements were made (AP + 1.8 mm) and
the approximate electrode track is shown by the solid line. The carbon-fiber microelectrode
was lowered within the rostral NAc shell in 200–300 μm increments beginning at 3.3 mm
from the skull, with release measured at each location. A plot of [CA]max normalized to the
maximum value observed along the track is shown in Figure 1C. Robust release was not
observed until a depth of 5.3 mm below the skull. Release reached a maximum at a depth of
6.5 mm and decreased to negligible values at 8.0 mm. Responses from misplaced electrodes
(determined via histology to be located in the caudate-putamen (CPu) near the ventricle or in
the NAc core) were discarded.
Electrically stimulated catecholamine release in the caudal NAc shell
Identical experiments were conducted in the caudal NAc shell. Electrical stimulation of the
MFB (example in Figure 2A) resulted in catecholamine release as identified by the cyclic
voltammograms (Figure 2A, right panel). The catecholamine concentration remained
elevated for a longer time than in the rostral NAc shell. When release in the caudal NAc
shell was evoked with VTA/SN stimulation, its amplitude was about one third of that
evoked by MFB stimulation. A histological record of one carbon-fiber microelectrode
placement in the caudal NAc shell (AP +1.0 mm) is shown in Figure 2B (right panel, black
arrow indicates the lesion site).
The vertical distribution of release sites in this region was also characterized with both MFB
and VTA/SN stimulation. The approximate vertical track is shown in Figure 2B (left panel).
The measured [CA]max, normalized to the maximum value observed along the track, is
shown in Figure 2C. With MFB stimulation, release began to become apparent at ~5.5 mm
below the skull. Maximal release was observed between 6.2 and 6.8 mm and then it
decreased. With VTA/SN stimulation, release was much lower and reached a maximum at
about 6.4 mm below the skull.
Comparison of catecholamine overflow in the rostral and caudal NAc shell
Catecholamine release and its time course in the rostral and caudal NAc shell was
quantitated and compared in the sites where maximal release was observed (Table 2).
Evoked [CA]max in the rostral NAc shell was statistically identical with stimulation of the
MFB or VTA/SN. The time to reach the maximum concentration (tmax) was ~0.6 s in the
rostral NAc shell with stimulation in either location, 0.2 s longer than the duration of the 60
Hz stimulation (0.4 s). The response time of the electrode is ~ 0.2 s, accounting for the delay
(Owesson-White et al. 2008). Following the stimulation, the time to return to half of the
maximal value (t1/2) in the rostral NAc shell was approximately the same with stimulation in
each region. Since the descending part of the curves is due to neuronal uptake (Giros et al.
1996), the similar clearance time suggests that the same transporter is responsible for the
removal of catecholamine in this region.
[CA]max in the caudal NAc shell was significantly lower than that in the rostral NAc shell
(F1, 38 = 1459, P < 0.0001). In the caudal NAc shell, [CA]max was approximately 3 times
greater when evoked in the MFB than when evoked in the VTA/SN (t = 6.7, d.f. = 15, P <
0.0001). The values of tmax in the caudal NAc shell were statistically longer than those
measured in the rostral NAc shell (F1, 41 = 11.35, P < 0.01). Similarly, the t1/2 values in the
caudal NAc shell were statistically longer than the values measured in the rostral NAc shell
(F1, 41 = 12.27, P < 0.005). The delayed tmax, coupled with the higher values of t1/2,
indicates uptake is weaker in the caudal NAc shell allowing greater diffusional transport of
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catecholamines from their release site (Venton et al. 2003). Again, the similarity of the t1/2
values in the caudal NAc shell suggests the transporter responsible for clearance is
independent of the stimulation site.
Influence of dopamine and norepinephrine drugs on extracellular catecholamine evoked
by VTA/SN and MFB stimulation in rostral and caudal NAc shell
The tissue content measurements (Table 1) show that norepinephrine tissue content is very
low within the rostral NAc shell, and thus the catecholamine responses in this region would
be expected to be due to dopamine. However, those in caudal NAc shell could be due to
either dopamine, norepinephrine, or both. To provide evidence for the specific
catecholamine(s) measured in each region, pharmacological agents were employed. For
dopamine, the D2 receptor antagonist, raclopride (2 mg/kg), and the monoamine transporter
blocker, cocaine (15 mg/kg), were used to enhance release and reduce uptake respectively.
For norepinephrine, the norepinephrine α2-adrenoceptor antagonist, yohimbine (6 mg/kg),
and the norepinephrine transporter blocker, desipramine (desmethylimipramine, 15 mg/kg),
were used to enhance release and reduce uptake respectively. The doses selected were based
on our prior work in the CPu, a dopamine rich region, and the ventral bed nucleus of the
stria terminalis, a norepinephrine rich region (Park et al. 2009).
The responses in the rostral NAc shell evoked by MFB or VTA/SN stimulation (60 Hz, 24
pulses) were unchanged 30 min following administration of yohimbine and desipramine
(representative example in Figure 3A). Neither [CA]max nor t1/2, a measure of the clearance
rate, were affected by the norepinephrine drugs in the rostral NAc shell (Table 3). In
contrast, raclopride and cocaine increased the responses in the rostral NAc shell
(representative example in Figure 3B). Raclopride significantly increased both [CA]max and
t1/2 (Table 3) and these increases were enhanced by cocaine. The increases were found
irrespective of the stimulus location (MFB or VTA/SN). Thus, although evoked
catecholamine in the rostral NAc shell is insensitive to drugs that alter norepinephrine
neurotransmission, it is sensitive to drugs that act on dopaminergic terminals.
In the caudal NAc shell, catecholamine signaling was altered by both dopaminergic and
noradrenergic drugs in contrast to the rostral NAc shell. The response in the caudal NAc
shell region evoked by the MFB stimulation showed a modest increase 30 min after
injection of yohimbine (representative result in Figure 4A, left, data from multiple animals
summarized in Table 3). Desipramine administered after yohimbine, further increased the
evoked response (representative example in Figure 4A, left). Raclopride and cocaine also
increased the responses in the caudal NAc shell evoked by either MFB or VTA/SN
stimulation (representative example Figure 4B, data from multiple animals summarized in
Table 3). Following these dopaminergic drugs, both [CA]max and t1/2 were increased in the
caudal NAc shell when evoked by either stimulation site (Table 3). With stimulation of the
VTA/SN, the evoked catecholamine response in the caudal NAc shell was not changed
following yohimbine alone, but did increase with the combination of desipramine and
yohimbine (representative example in Figure 4A, right, Table 3). This combination of
noradrenergic drugs led to significant increases in [CA]max and t1/2 in the caudal NAc shell
with both stimulation sites (Table 3) in contrast to the rostral NAc shell (F1, 44 = 55.42, P <
0.0001 for [CA]max, and F1, 43 = 14.43, P < 0.005 for t1/2). The combination of raclopride
and cocaine increased t1/2 of the response evoked by either the MFB or by the VTA/SN
stimulation more in the caudal NAc shell than in the rostral NAc shell (Figure 4B, Table 3)
(F1, 42 = 10.40, P < 0.01). Thus in the caudal NAc shell, catecholamine transmission is
sensitive to both noradrenergic and dopaminergic drugs.
In this study, cocaine was used as a catecholamine uptake inhibitor because the effects of
cocaine seeking and self-administration on dopamine neurotransmission were previously
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studied in the NAc (Phillips et al. 2003; Owesson-White et al. 2009). However, cocaine is
not a selective DAT inhibitor. Therefore, we also studied the effect of GBR 12909, a
selective DAT inhibitor, on catecholamine release evoked by MFB stimulation in the rostral
and caudal NAc shell. GBR 12909, administered after raclopride, further increased the
response in the rostral and caudal NAc shell region evoked by the MFB stimulation
(representative result in Supplementary Fig. 2, data from multiple animals summarized in
Table 3). There were no significant differences in the increases of [CA]max and t1/2 by
raclopride followed by GBR 12909 between rostral and caudal NAc shell. The effects of
GBR 12909 on evoked dopamine occur more slowly than with cocaine (Espana et al. 2008;
Budygin et al. 2000). Therefore, comparison of the GBR 12909 and cocaine effects after
administration of raclopride can differ because of their different time courses of action.
Catecholamine transient release in the rostral and caudal NAc shell after administration of
raclopride and cocaine
Figure 5 shows catecholamine fluctuations 15 min before and after raclopride and cocaine in
both the rostral and caudal NAc shell. The fluctuations before drug in the color plots
represent the electrical noise of the system. Following administration of both raclopride (2
mg/kg) and cocaine (15 mg/kg), fluctuations in the voltammetric responses were observed
(Figure 5B) while there was no detectable signal before the administration of the drugs
(Figure 5A). The color plots, and cyclic voltammograms extracted from them (Figure 5B)
clearly reveal that these are transient increases in catecholamines that occur without
electrical stimulation. This was confirmed by principal component regression of the
voltammograms (Heien et al. 2005). These catecholamine fluctuations are similar to the
dopamine transients that we previously reported in the CPu of anesthetized rats following
similar drug treatments (Venton & Wightman 2007). As in the CPu, dopamine autoreceptor
blockade alone was insufficient to evoke transients in anesthetized rats. However, 5 min
following a subsequent injection of cocaine, transients were induced that reached a
maximum amplitude within 15 min and continued for 20 to 30 min. Transients were
observed following the dopaminergic drugs in the rostral NAc shell in 9 out of 12 rats while
only 4 of 16 rats showed weak transients in the caudal NAc shell. Drug-evoked transients
were not observed following administration of the noradrenergic drugs, yohimbine (6 mg/
kg) and desipramine (15 mg/kg), in either the rostral or caudal NAc shell.
The maximal concentration of transients following cocaine and raclopride within the caudal
NAc shell, 0.05 ± 0.01 μM (n = 4 rats), was much lower than in the rostral NAc shell, 0.17 ±
0.02 μM (n = 9 rats, t = 4.7, d.f.=11, P = 0.0006). The average transient frequency was ~
0.35 Hz (10.5 ± 0.5 transients per 30 sec, n = 8) for rostral NAc shell. In addition, the
maximal concentration of transient (0.14 ± 0.03 μM, n = 5) and average transient frequency
(0.38 Hz, 11.5 ± 0.4 transients per 30 sec, n = 5) following GBR 12909 and raclopride in the
rostral NAc shell were not significantly different from the values following cocaine and
raclopride (Supplementary Fig. 2). It was difficult to compile a frequency average for
transients in the caudal NAc shell due to the absence of catecholamine transients in most
rats. The drug-induced transients in the rostral NAc shell were observed at similar depths
(6.0–7.5 mm from the skull surface) as stimulated release (compare Supplementary Figure 3
with Figures 1C and 2C).
Discussion
Here, we examined the evoked release of catecholamines in two NAc subregions with fast-
scan cyclic voltammetry. The sensor employed, the carbon-fiber microelectrode, has micron
dimensions allowing investigation of these two subregions that are only separated by ~800
μm. Catecholamine release was evoked by either stimulation of the MFB, a major ascending
pathway that contains both dopaminergic and noradrenergic neurons (Ungerstedt 1971), or
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the VTA/SN region. Stimulation in the latter region activates dopamine cell bodies (Garris
& Wightman 1994a) as well as the VNB that passes through these regions (Ungerstedt
1971). The major finding of this work is that catecholamine release in the rostral NAc shell
is predominantly from dopaminergic neurons whereas in the caudal NAc shell release of
both catecholamines can be evoked. This finding is consistent with the neurochemical
content of the subregions of the NAc shell. Our findings also show that measurable
fluctuations in extracellular dopamine arise following combined administration of a
dopamine autoreceptor antagonist and a catecholamine uptake inhibitor, cocaine, or a
dopamine uptake inhibitor, GBR 12909. In contrast, simultaneous inhibition of
noradrenergic autoreceptors and uptake does not evoke measurable transients in anesthetized
rats. Our data are consistent with previous immunohistochemistry studies have shown that
noradrenergic neurons innervate the caudal NAc shell to a greater degree than the rostral
region (Delfs et al. 1998), whereas dopaminergic neurons originating in the VTA project to
both subregions (Ikemoto 2007; Swanson 1982). The current study not only provides more
definitive evidence that catecholamine transmission within the rostral NAc shell measured
by FSCV is due primarily to dopamine transmission, but also indicates that norepinephrine
signaling is restricted to the caudal NAc shell. This is of interest because it has been
suggested that the noradrenergic projection in the caudal NAc shell may modulate processes
associated with stress, behavior state, or reinforcement via its actions within this region
(Hajnal & Norgren 2004).
Extracellular measurements of catecholamines in the NAc shell
Our chromatographic analysis of tissue content (Table 1) confirmed that dopamine is the
predominant catecholamine in the rostral NAc shell whereas ~ 30 % of the catecholamine in
the caudal NAc shell was norepinephrine. Extracellular norepinephrine and dopamine
measurements by microdialysis within the NAc also showed that dopamine is the
predominant catecholamine in the NAc core whereas both norepinephrine and dopamine are
present in dialysate from the NAc shell (McKittrick & Abercrombie 2007;Hajnal & Norgren
2004;Carboni et al. 2006). In this study, our voltammetric measurements confirmed that
stimulation of ascending pathways evokes catecholamine release in both the rostral and
caudal NAc shell. Stimulation at 60 Hz at both of the sites investigated evokes a rapid
increase in catecholamines throughout the NAc shell. [CA]max in the caudal NAc shell was
significantly lower than that in the rostral NAc shell although tissue content is similar. This
discrepancy between [CA]max and dopamine content may reflect our failure to dissect
exactly the same nuclei each time. Furthermore, norepinephrine release has been shown to
be a smaller fraction of total stores than is dopamine release (Garris & Wightman 1995).
Thus, tissue content is also not always proportional to catecholamine transmission in the
terminal region. Consistent with our evoked release, extracellular dopamine has been shown
to have a rostral to caudal gradient (Heidbreder & Feldon 1998). The time to reach the
maximum concentration (tmax) in the rostral NAc shell is 0.2 s longer than the stimulus
duration, a consequence of the finite response time of the electrode (Owesson-White et al.
2008). The clearance rates (measured as t1/2,Table 2) were slower in the caudal NAc shell
than in the rostral region. Consistent with this, the dopamine transporter (DAT) is less
densely distributed in the caudal NAc shell than in the rostral region (Pilotte et al. 1996).
The norepinephrine transporter (NET) exhibits a similar distribution to that of the
noradrenergic terminals in both the NAc shell of rats (Schroeter et al. 2000) and humans
(Tong et al. 2007). Thus, in the rostral NAc shell, uptake is primarily controlled by the DAT
whereas in the caudal region both NET and DAT contribute to the observed clearance.
To establish the nature of the catecholamine detected we used pharmacological agents. In
prior work we and others have shown that release from dopaminergic terminals is enhanced
by antagonists of the dopamine autoreceptor and prolonged by inhibition of the DAT, but is
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insensitive to drugs that act on noradrenergic neurons (Park et al. 2009; Carboni et al. 2006;
Gobert et al. 1998; Palij & Stamford 1992).
Conversely, release from noradrenergic terminals is insensitive to dopamine specific drugs
but is enhanced by antagonists of the norepinephrine autoreceptor and inhibition of NET
(Park et al. 2009; Gobert et al. 1998). Here, such pharmacological studies confirmed that
dopamine was the predominant species released in the rostral NAc shell, an observation
consistent with the microdialysis, anatomical, and tissue content studies. In contrast, release
in the caudal NAc shell was affected by both a norepinephrine autoreceptor antagonist and
an inhibitor of the NET as well as the dopaminergic drugs. Therefore, we conclude that
stimulated release in the caudal NAc shell is a mixture of dopamine and norepinephrine.
Catecholamine projections to the rostral and caudal NAc shell
To evoke dopamine release in the rostral NAc shell, we chose the MFB and the VTA/SN
region for placement of the stimulating electrode. Stimulation of both regions resulted in
similar amounts of dopamine release in the rostral NAc shell, suggesting the same neurons
were stimulated in each case. This is likely the case because VTA dopaminergic neurons
project through the MFB en route to terminal regions (Ungerstedt 1971; Ikemoto 2007). To
evoke catecholamine release in the caudal NAc shell, we stimulated the same two regions
but the amounts released were quite different. As well as dopamine release, norepinephrine
release might be expected with stimulation of the VTA/SN region because the ventral
noradrenergic bundle (VNB) originating from A2 and A1 neurons passes through this region
(Ungerstedt 1971). We have shown previously that electrical stimulation of the VTA/SN
activates at least a portion of the VNB because norepinephrine release was detected in the
ventral bed nucleus of the stria terminalis (Park et al. 2009). Release in the caudal NAc shell
was greater with MFB stimulation indicating that more catecholamine terminals were
activated. These could include the fibers of the DNB that also pass through the MFB
(Berridge et al. 1997).
The data obtained in the caudal NAc shell cannot be used to distinguish the amount of
norepinephrine and dopamine that are released because the cyclic voltammograms for
dopamine and norepinephrine are virtually identical (Heien et al. 2004; Park et al. 2009).
Confounding the pharmacological data is the fact that NET can modulate a portion of the
extracellular dopamine because it has a greater affinity for dopamine than the DAT (Moron
et al. 2002). However, the results in the rostral NAc shell can be interpreted with much more
confidence. The data clearly show that dopamine is by far the predominant catecholamine
detected. Thus, this work validates our prior measurements of dopamine concentration
fluctuations during intracranial self-stimulation (Owesson-White et al. 2008) and during
cocaine administration (Aragona et al. 2009).
Dopamine transients occur following combined inhibition of dopamine uptake and
autoreceptors
A key feature of dopamine neurotransmission are the naturally occurring dopamine
concentration transients that are observed in awake animals (Wightman et al. 2007). They
occur as a consequence of burst firing of dopaminergic neurons that can be evoked by
activation of NMDA receptors in the VTA (Sombers et al. 2009). However, in deeply
anesthetized animals these are rarely seen (Venton & Wightman 2007), a finding that is
consistent with the reduction in burst firing that occurs in anesthetized animals (Fa et al.
2003). Previously we showed that dopamine transients can occur within the CPu of an
anesthetized rat following administration of a D2 receptor antagonist and a catecholamine
transporter blocker (Venton & Wightman 2007). The results shown here indicate that
dopamine transients of similar origin can occur in the NAc shell. Electrophysiological
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studies of VTA dopaminergic studies have shown that the combined regimen of cocaine and
a D2 antagonist lead to increased burst firing and slow rhythmic oscillations in the firing rate
of dopamine neurons in anesthetized rats (Shi et al. 2004). Even though the anesthesia, dose
of drugs used, and route of administration differed, the frequency of the cell firing
oscillations (0.74 Hz) was remarkably similar to the frequency (0.35 Hz) of the dopamine
concentration transients reported here. Inhibition of autoreceptors and uptake remove two of
the key, negative-feedback components that regulate dopaminergic neurons. Removal of
negative feedback frequently leads to oscillatory behavior. Note, however, that similar
inhibition of noradrenergic negative feedback does not cause oscillatory behavior.
Sequential administration of a noradrenergic autoreceptor antagonist and noradrenergic
uptake inhibitor do not give rise to transients in the caudal NAc shell or the bed nucleus of
the stria terminalis (Park et al. 2009) even though there is sufficient norepinephrine present
in those regions to contribute to robust electrically evoked responses.
Conclusion
The present results show that norepinephrine is regulated in the caudal NAc shell by
norepinephrine autoreceptors and uptake transporters. This result suggests that dopaminergic
and noradrenergic transmission within the caudal NAc shell may play significantly different
roles in regulating the behavioral and physiologic responses associated with drug abuse,
physical stressors and other rewarding and aversive stimuli, compared to the rostral NAc
shell.
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Electrically evoked catecholamine responses measured in the rostral NAc shell. (A)
Representative maximal catecholamine responses in the rostral NAc shell were evoked by
MFB (solid line) or VTA/SN (dotted line) stimulation (60 Hz, 24 pulses). The bars under the
current traces denote the period of electrical stimulation. Insets: background-subtracted
cyclic voltammograms measured during the evoked responses. (B) Solid line in the
schematic diagram illustrate the approximate path of the carbon-fiber microelectrodes
through the rostral NAc shell (left). The location of the carbon-fiber microelectrode tip in
the rostral NAc shell (right) was visualized by the electrolytic lesion (black arrow). The
coronal section is adapted from the atlas of Paxinos and Watson (2007). (C) Maximal
stimulated release during electrical stimulation measured in the rostral NAc shell as the
carbon-fiber microelectrode was lowered in small increments through the regions shown in
B. The relative response is the concentration at particular depth (Cdx) divided by the
maximum concentration (Cdmax). The catecholamine response in the rostral NAc shell was
evoked by MFB or VTA/SN stimulation (60 Hz, 24 pulses). Abbreviations used: CPu,
caudate-putamen.
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Electrically evoked catecholamine responses measured in the caudal NAc shell. (A)
Representative maximal catecholamine responses at the peak current for catecholamines in
the caudal NAc shell. The bars under the current traces denote the period of electrical
stimulation (60 Hz, 24 pulses). Insets: background-subtracted cyclic voltammograms
measured during the evoked responses. (B) Solid line in the schematic diagram illustrate the
approximate path of the carbon-fiber microelectrodes in the caudal NAc shell (left). The
placement of the carbon-fiber microelectrode tip in the caudal NAc shell (right) was
visualized by the electrolytic lesion (black arrow). The coronal section is adapted from the
atlas of Paxinos and Watson (2007). (C) Maximal stimulated release during electrical
stimulation measured in the caudal NAc shell as the carbon-fiber microelectrode was
lowered in small increments through the regions shown in B. The relative response is the
response at particular depth (Cdx) divided by the maximum concentration (Cdmax). The
catecholamine response in the caudal NAc shell was evoked by MFB or VTA/SN
stimulation (60 Hz, 24 pulses). Abbreviations used: CPu, caudate-putamen.
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Effect of yohimbine (Yo, 5 mg/kg), desipramine (DMI, 15 mg/kg), raclopride (Ra, 2 mg/kg)
and cocaine (Co, 15 mg/kg) on catecholamine overflow in the rostral NAc shell.
Representative recordings of extracellular catecholamine in the rostral NAc shell evoked by
MFB (left) or VTA/SN stimulation (right) in the presence of (A) Yo (---) and Yo + DMI
(…), (B) Ra (---) and Ra + Co (…) at 60 Hz with 24 pulses. The bars under the current
traces indicate the period of electrical stimulation.
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Effect of yohimbine (Yo, 5 mg/kg), desipramine (DMI, 15 mg/kg), raclopride (Ra, 2 mg/kg)
and cocaine (Co, 15 mg/kg) on catecholamine overflow in the caudal NAc shell.
Representative recordings of extracellular catecholamine in the rostral shell evoked by MFB
stimulation (left) or VTA/SN (right) in the presence of (A) Yo (---) and Yo + DMI (…), (B)
Ra (---) and Ra + Co (…) at 60 Hz with 24 pulses. The bars under the current traces indicate
the period of electrical stimulation.
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Drug induced catecholamine concentration transients in the rostral and caudal NAc shell
after raclopride (2 mg/kg, i.p.) and cocaine (15 mg/kg, i.p.). Two-dimensional color plot
representation of the background-subtracted cyclic voltammograms collected over 30 sec
(A) before and (B) following administration of drugs in the rostral and caudal NAc shell.
Catecholamine concentration changes are apparent in the color plots (B) at the potential for
its oxidation (~ 0.65 V) and its reduction (−0.2 V). Principal component regression was used
to extract the time course of the catecholamine concentration transients (lower traces in A
and B). Times are indicated by the vertical bars. Inset: Cyclic voltammograms recorded at
the time indicated by the arrows were identical to those for a catecholamine.
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Table 1
Monoamine content in the NAc shell. Values represent the mean ± S.E.M.
NAc Shell Rostral (AP + 1.9 to 1.4mm) (μg/g, n = 15 samples) Caudal (AP + 1.2 to 0.7 mm) (μg/g, n = 12 samples)
Norepinephrine 0.04 ± 0.04 1.14 ± 0.55*
Dopamine 3.99 ± 0.73 3.09 ± 0.57
*
Significantly different from norepinephrine in the caudal NAc shell (P < 0.05, unpaired t-test).
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Table 2
Parameters measured during the electrically evoked (300 μA, 60 Hz, 24 pulses) catecholamine responses in
the rostral and caudal NAc shell.
(n ≥ 8) CA in rostral shell CA in caudal shell
Stimulation MFB VTA/SN MFB VTA/SN
[CA]max μM 2.00 ± 0.26* 1.78 ± 0.28* 0.65 ± 0.06 0.18 ± 0.03
tmax (s) 0.65 ± 0.02* 0.60 ± 0.02* 0.83 ± 0.07 0.97 ± 0.09
t1/2 (s) 1.12 ± 0.05* 1.01 ± 0.04* 1.84 ± 0.24 1.52 ± 0.17
[CA]max is the maximal evoked catecholamine concentration; tmax is the time to reach to the peak response from the start of the stimulation,; t1/2
is the time required for catecholamine overflow to decay to 50 % of the maximum. Values represent the mean ± S.E.M.
*
(P < 0.05, t-test with Bonferroni correction) indicates significantly different from caudal NAc shell.
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